Published in Hospital Law Weekly, January 5th, 2006
According to a report from the United States, "An estimated 20% of patients with rheumatoid arthritis (RA) receive tumor necrosis factor (TNF) inhibitor treatment. This paper presents the results of an online survey of U.S. rheumatologists (1,023 respondents) conducted in April 2005 on issues relating to use of TNF inhibitors in RA."
"The primary determinant of TNF inhibitor use among the participating rheumatologists was physician preference rather than patient preference or payor guidelines....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.